Human Pathogenic Papillomaviruses

Human Pathogenic Papillomavirus Types: An Update.- Primer-Directed Sequencing of Human Papillomavirus Types.- Evolution of Papillomaviruses.- Epidemiology of Cervical Human Papillomavirus Infections.- Functions of Human Papillomavirus Proteins.- Immortalization and Transformation of Human Cells by Human Papillomavirus.- Protein Phosphatase 2A and the Regulation of Human Papillomavirus Gene Activity.- Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types.- Epidermodysplasia Verruciformis: Immunological and Clinical Aspects.- Papillomaviruses and Cancer of the Upper Digestive and Respiratory Tracts.- In Vitro Systems for the Study and Propagation of Human Papillomaviruses.- Immune Response to Human Papillomaviruses and the Prospects for Human Papillomavirus-Specific Immunisation.- Vaccination Against Papillomavirus in Cattle.

[1]  P. Howley,et al.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator , 1987, Cell.

[2]  J. Sundberg.  Papillomavirus Infections in Animals , 1987 .

[3]  D. Hanahan,et al.  Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome , 1989, Molecular and cellular biology.

[4]  E. de Villiers,et al.  Human Papillomavirus in Squamous Cell Carcinoma, Leukoplakia, Lichen Planus, and Clinically Normal Epithelium of the Oral Cavity , 1990, The Annals of otology, rhinology, and laryngology.

[5]  T. Kanda,et al.  Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7 , 1989, Journal of virology.

[6]  L. Brinton,et al.  Invasive cervical cancer and smoking in Latin America. , 1989, Journal of the National Cancer Institute.

[7]  S. Syrjänen,et al.  Two different human papillomavirus (HPV) types associated with oral mucosal lesions in an HIV-seropositive man. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[8]  M. Lehtinen,et al.  Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma. , 1992, Journal of clinical pathology.

[9]  K. Shah,et al.  Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera , 1987, Journal of virology.

[10]  R. Lotan,et al.  Inhibition of growth and squamous‐cell differentiation markers in cultured human head and neck squamous carcinoma cells by β‐all‐trans retinoic acid , 1990 .

[11]  I. Frazer,et al.  Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. , 1990, The Journal of general virology.

[12]  N. Christensen,et al.  Skin test to assess immunity against cottontail rabbit papillomavirus antigens in rabbits with progressing papillomas or after papilloma regression. , 1993, The Journal of investigative dermatology.

[13]  H. D. Chen,et al.  Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: an immunohistopathologic study with monoclonal antibodies. , 1989, Journal of the American Academy of Dermatology.

[14]  A. Whittemore,et al.  Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. , 1989, Journal of the National Cancer Institute.

[15]  N. B. Atkin,et al.  Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors. , 1982, Cancer genetics and cytogenetics.

[16]  M. Hummel,et al.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes , 1992, Journal of Virology.

[17]  D. Jenkins,et al.  Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection , 1987 .

[18]  F. Hoppe-Seyler,et al.  Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. , 1992, Nucleic acids research.

[19]  G. Grindlay,et al.  Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. , 1991, Virology.

[20]  M. Botchan,et al.  Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. , 1989, Genes & development.

[21]  C. Slaughter,et al.  Association of protein phosphatase 2A with polyoma virus medium tumor antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Rouse,et al.  Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. , 1992, Journal of immunology.

[23]  D. Wallach,et al.  Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. , 1991, Cancer research.

[24]  K. Hatch,et al.  Folate deficiency and cervical dysplasia. , 1992, JAMA.

[25]  P. Gallimore,et al.  Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. , 1990, Virology.

[26]  Y. Chardonnet,et al.  T-cell subsets and Langerhans cells in wart lesions. , 1983, Immunology letters.

[27]  J. Kienzler.  Humoral immunity to human papillomaviruses. , 1985, Clinics in dermatology.

[28]  B. Gloss,et al.  During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. , 1992, Nucleic acids research.

[29]  S. Vermund,et al.  Comparison of Cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus. , 1989, American Journal of Obstetrics and Gynecology.

[30]  M. Ivey-Hoyle,et al.  Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts , 1993, Journal of virology.

[31]  N. Christensen,et al.  Morphometric analysis and identification of infiltrating leucocytes in regressing and progressing shope rabbit papillomas , 1991, International journal of cancer.

[32]  J. McDougall,et al.  Viral integration and fragile sites in human papillomavirus‐lmmortalized human keratinocyte cell lines , 1992, Genes, chromosomes & cancer.

[33]  J. Dillner,et al.  Induction of bovine papillomavirus E2 gene expression and early region transcription by cell growth arrest: correlation with viral DNA amplification and evidence for differential promoter induction , 1990, Journal of virology.

[34]  J. McDougall,et al.  Characterization of primary human keratinocytes transformed by human papillomavirus type 18 , 1988, Journal of virology.

[35]  D. Lowy,et al.  Bovine papilloma virus-transformed cells contain multiple E2 proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[37]  J. Clements,et al.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens , 1992, Clinical Microbiology Reviews.

[38]  K. Vousden,et al.  Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation , 1991, Cell.

[39]  L. Taichman,et al.  The Expression of Papillomaviruses in Epithelial Cells , 1987 .

[40]  B. Steinberg,et al.  Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. , 1992, The Journal of general virology.

[41]  F. Pass,et al.  Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis. , 1977, Journal of the National Cancer Institute.

[42]  H. Pfister,et al.  Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups , 1993, Journal of virology.

[43]  S. Suhai,et al.  Human papillomavirus type 16 DNA sequence. , 1985, Virology.

[44]  H. Bernard,et al.  Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. , 1993, The Journal of infectious diseases.

[45]  H. Pfister.  Molecular Biology of Genital HPV Infections , 1990 .

[46]  A. Evans.  Epidemiological Concepts and Methods , 1982 .

[47]  W. Winkelstein,et al.  Smoking and cervical cancer--current status: a review. , 1990, American journal of epidemiology.

[48]  K. Kinzler,et al.  Oncogenic forms of p53 inhibit p53-regulated gene expression. , 1992, Science.

[49]  H. zur Hausen.  Human papillomaviruses and their possible role in squamous cell carcinomas. , 1977, Current topics in microbiology and immunology.

[50]  A. Cambon-Thomsen,et al.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[52]  H. Hausen,et al.  Chromatin structure and transcriptional regulation of human papillomavirus type 18 DNA in hela cells , 1989, Molecular carcinogenesis.

[53]  M. Debiec‐Rychter,et al.  Chromosomal characterizations of human nasal and nasopharyngeal cells immortalized by human papillomavirus type 16 DNA. , 1991, Cancer genetics and cytogenetics.

[54]  M. Stanley,et al.  Production of human papillomavirus type 16 virions in a keratinocyte cell line , 1990, Journal of virology.

[55]  L. Gissmann,et al.  Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[56]  H. Nakshatri,et al.  Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA , 1988, Nature.

[57]  E. Franco.  The Sexually Transmitted Disease Model for Cervical Cancer: Incoherent Epidemiologic Findings and the Role of Misclassification of Human Papillomavirus Infection , 1991, Epidemiology.

[58]  A. Meisels,et al.  Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. , 1976, Acta cytologica.

[59]  E. Androphy,et al.  Enhanced degradation of p53 protein in HPV‐6 and BPV‐1 E6‐immortalized human mammary epithelial cells. , 1993, The EMBO journal.

[60]  P. Gallimore.  Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;. , 1974, Journal of molecular biology.

[61]  N. Maitland,et al.  Detection of human papillomavirus DNA in biopsies of human oral tissue. , 1987, British Journal of Cancer.

[62]  J. Dillner,et al.  Serological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri , 1990, Journal of clinical microbiology.

[63]  C. Thomssen,et al.  High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3 , 1991, Nature.

[64]  P. Chambon,et al.  Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.

[65]  H. Kashima,et al.  Association of human papillomavirus subtype and clinical course in respiratory papillomatosis , 1984, The Laryngoscope.

[66]  W. Evans,et al.  Acute bracken poisoning in homogastric and ruminant animals , 1982 .

[67]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[68]  C. Mok,et al.  Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. , 1992, Anticancer research.

[69]  C. Meijer,et al.  Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection. , 1991, The Journal of general virology.

[70]  D. Lowy,et al.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J. Dillner.  Mapping of linear epitopes of human papillomavirus type 16: The E1, E2, E4, E5, E6 and E7 open reading frames , 1990, International journal of cancer.

[72]  Kathleen R. Cho,et al.  Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[73]  P. Howley,et al.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes , 1992, Journal of virology.

[74]  D. Lowy,et al.  The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture , 1991, Journal of virology.

[75]  H. Pfister,et al.  Characterization of human papillomavirus 3 in warts of a renal allograft patient. , 1979, The Journal of investigative dermatology.

[76]  P. Cresswell,et al.  Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.

[77]  S. Barthold,et al.  Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[78]  G. Orth,et al.  The search for a culture system for papillomavirus. , 1984, The Journal of investigative dermatology.

[79]  C. Woodworth,et al.  HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes. , 1990, Virology.

[80]  P. Howley,et al.  Transient replication of human papillomavirus DNAs , 1992, Journal of virology.

[81]  T. Löning,et al.  In situ detection of human papillomavirus types 13 and 32 in focal epithelial hyperplasia of the oral mucosa. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[82]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[83]  S. Vermund,et al.  Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. , 1992, The Journal of pediatrics.

[84]  J. McDougall,et al.  Cytogenetic analysis of eight human papillomavirus immortalized human keratinocyte cell lines , 1989, International journal of cancer.

[85]  V. Band,et al.  Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[86]  S. Saarikoski,et al.  Natural Killer (NK) Cells with HNK‐1 Phenotype in the Cervical Biopsies of Women Followed‐Up for Human Papillomavirus (HPV) Lesions , 1986, Acta obstetricia et gynecologica Scandinavica.

[87]  Y. L. Lin,et al.  Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. , 1992, Virology.

[88]  K. Münger,et al.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein , 1992, Journal of virology.

[89]  D. Asselineau,et al.  Reconstruction of ‘simplified’ skin: control of fabrication , 1984, The British journal of dermatology.

[90]  B. Gloss,et al.  The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element , 1990, Journal of virology.

[91]  L. Moreland,et al.  Delayed type hypersensitivity , 2004 .

[92]  D. W. Morgan,et al.  Human papilloma virus and carcinoma of the laryngopharynx , 1991, The Journal of Laryngology & Otology.

[93]  C. Meijer,et al.  Detection of human papillomavirus and Epstein-Barr virus DNA sequences in oral mucosa of HIV-infected patients by the polymerase chain reaction. , 1990, The American journal of pathology.

[94]  J. Blomberg,et al.  Detection of iga antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia , 1989, International journal of cancer.

[95]  E. Harlow,et al.  Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.

[96]  E. Thorsby,et al.  HLA antigens and cervical carcinoma , 1992, Nature.

[97]  B. Drescher,et al.  Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind , 1992, Journal of virology.

[98]  Leland Hartwell,et al.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.

[99]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[100]  T. Onda,et al.  Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer. , 1992, Virology.

[101]  G. Dougan,et al.  Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16 , 1991, Journal of virology.

[102]  K. Schallreuter,et al.  The human epidermis , 1995, Proceedings of the Nutrition Society.

[103]  R. Zaino,et al.  Laboratory production in vivo of infectious human papillomavirus type 11 , 1987, Journal of virology.

[104]  C. Lai,et al.  Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. , 1991, American journal of clinical pathology.

[105]  J. DiPaolo,et al.  Human papillomavirus type 18 DNA is integrated at a single chromosome site in cervical carcinoma cell line SW756 , 1987, Journal of virology.

[106]  M. Ewen,et al.  Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein , 1991, Cell.

[107]  Steven Wolinsky,et al.  Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice , 1990, Journal of virology.

[108]  D. McCance,et al.  Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes , 1992, Journal of virology.

[109]  D. Galloway,et al.  Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11 , 1992, Journal of virology.

[110]  Steven Wolinsky,et al.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. , 1992, Human pathology.

[111]  J. Becker,et al.  Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. , 1985, The Journal of investigative dermatology.

[112]  J. Rothbard,et al.  Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. , 1990, The Journal of general virology.

[113]  G. Gross.  Interferon and genital warts. , 1988, JAMA.

[114]  K. Münger,et al.  Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins , 1992, Journal of virology.

[115]  W. Koff,et al.  Development of a vaccine for the prevention of AIDS, a critical appraisal. , 1992, Vaccine.

[116]  S. Koi,et al.  Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. , 1989, Virology.

[117]  H. Bernard,et al.  Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia , 1989, Journal of virology.

[118]  T. Curran,et al.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. , 1990, Science.

[119]  D. DiMaio,et al.  Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16 , 1991, Journal of virology.

[120]  R. Minnaar,et al.  Modulation of the human papillomavirus type 16 induced transformation and transcription by deletion of loci on the short arm of human chromosome 11 can be mimicked by SV40 small t. , 1992, Virology.

[121]  A. Berk,et al.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein , 1992, Nature.

[122]  P. Howley,et al.  Role of the human papillomaviruses in human cancer. , 1991, Cancer research.

[123]  D. Mack,et al.  A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[124]  M. Krcmar,et al.  Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. , 1990, The Journal of general virology.

[125]  M. M. Pater,et al.  RU486 inhibits glucocorticoid hormone-dependent oncogenesis by human papillomavirus type 16 DNA. , 1991, Virology.

[126]  W. Jarrett.  Bracken fern and papilloma virus in bovine alimentary cancer. , 1980, British medical bulletin.

[127]  I. Hirsch,et al.  Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus types 6b and 11 in human sera. , 1990, Acta virologica.

[128]  W. Benedict,et al.  Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids. , 1986, Cancer research.

[129]  E. de Villiers,et al.  Unusual HPV types in oral warts in association with HIV infection. , 1988, Journal of oral pathology.

[130]  N. B. Atkin,et al.  Deficiency of all or part of chromosome 11 in several types of cancer: significance of a reduction in the number of normal chromosomes 11. , 1988, Cytogenetics and cell genetics.

[131]  K. Münger,et al.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A , 1988, Cell.

[132]  D. Galloway,et al.  Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope , 1989, Journal of virology.

[133]  M. Ustav,et al.  Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. , 1991, The EMBO journal.

[134]  B. Polk,et al.  Rarity of Cesarean Delivery in Cases of Juvenile‐Onset Respiratory Papillomatosis , 1986, Obstetrics and gynecology.

[135]  D. Shibata,et al.  Detection of Human Papillomavirus in Formalin‐Fixed, Invasive Squamous Carcinomas Using the Polymerase Chain Reaction , 1989, The American journal of surgical pathology.

[136]  Harald,et al.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells , 1990, Journal of virology.

[137]  H. Tagami,et al.  Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts , 1986, Cancer.

[138]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[139]  T. R. Broker,et al.  Characterization of an HPV type 11 isolate propagated in human foreskin implants in nude mice. , 1989, Virology.

[140]  M. Campo,et al.  A new papillomavirus associated with alimentary cancer in cattle , 1980, Nature.

[141]  W. Phelps,et al.  Evaluation of sexually abused and nonabused young girls for intravaginal human papillomavirus infection. , 1992, American journal of diseases of children.

[142]  S. Evans,et al.  The Changing Prevalence of Cervical Human Papilloma Virus Infection , 1990, The Australian & New Zealand journal of obstetrics & gynaecology.

[143]  E. Fuchs,et al.  Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R. Good,et al.  Propagation of human wart virus in tissue culture , 1975, Nature.

[145]  P. Howley,et al.  The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein. , 1992, The EMBO journal.

[146]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[147]  D. Lowy,et al.  Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity , 1992, Journal of virology.

[148]  E. de Villiers,et al.  Papillomavirus DNA in human tongue carcinomas , 1985, International journal of cancer.

[149]  G. Riou,et al.  C-myc PROTO-ONCOGENE EXPRESSION AND PROGNOSIS IN EARLY CARCINOMA OF THE UTERINE CERVIX , 1987, The Lancet.

[150]  D. Galloway,et al.  Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins , 1988, Journal of virology.

[151]  V. Diehl,et al.  Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma , 1982, Journal of virology.

[152]  H. zur Hausen.  Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? , 1982, Lancet.

[153]  J. DiPaolo,et al.  Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA , 1987, Journal of virology.

[154]  D. Lowy,et al.  Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity , 1989, Journal of virology.

[155]  C. Meyers,et al.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. , 1992, Science.

[156]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[157]  G. Michalopoulos,et al.  Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. , 1975, Experimental cell research.

[158]  G. Grindlay,et al.  Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. , 1994, Virology.

[159]  S. Jablonska,et al.  Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. , 1972, Cancer research.

[160]  J. van der Noordaa,et al.  Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA , 1988, Journal of virology.

[161]  H. Hausen,et al.  Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. , 1992, The EMBO journal.

[162]  W. F. Noyes.  STUDIES ON THE HUMAN WART VIRUS. II. CHANGES IN PRIMARY HUMAN CELL CULTURES. , 1965, Virology.

[163]  S. Grossman,et al.  E6 protein of human papillomavirus type 18 binds zinc. , 1989, Oncogene.

[164]  D. Lowy,et al.  E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene , 1986, Journal of virology.

[165]  A. Wyllie,et al.  Papillomaviruses and human cancer. , 1990, Human pathology.

[166]  H. Hausen,et al.  Retinoic acid‐mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non‐tumorigenic and tumorigenic HeLa hybrid cells. , 1992, The EMBO journal.

[167]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[168]  J. Felsenstein.  Phylogenies from molecular sequences: inference and reliability. , 1988, Annual review of genetics.

[169]  K. Holmes,et al.  Epidemiology of genital human papillomavirus infection. , 1988, Epidemiologic reviews.

[170]  N. Christensen,et al.  Antibody-mediated neutralization in vivo of infectious papillomaviruses , 1990, Journal of virology.

[171]  Moyses Szklo,et al.  Herpes simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer , 1991, International journal of cancer.

[172]  H. Hausen,et al.  Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non‐tumorigenic human keratinocytes under non‐selective conditions. , 1991, The EMBO journal.

[173]  M. Bedell,et al.  The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells , 1987, Journal of virology.

[174]  R. Zaino,et al.  In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata , 1986, Journal of virology.

[175]  I. Seif,et al.  A common function for polyoma virus large-T and papillomavirus E1 proteins? , 1984, Nature.

[176]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[177]  Kenneth M. Yamada,et al.  Collagen, and Laminin in Human Skin Variable Expression in Basal and Squamous Cell Carcinomas , 1989 .

[178]  L. Gissmann,et al.  The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. , 1985, The Journal of general virology.

[179]  A. Levine,et al.  Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells , 1981, Molecular and cellular biology.

[180]  H. Klinger.  Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes. , 1980, Cytogenetics and cell genetics.

[181]  J. Horváth,et al.  Adenovirus transformation revertant resistant to retransformation by E1 but not by SV40-T and HPV16-E7 oncogenes. , 1992, Virology.

[182]  V. Defendi,et al.  Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. , 1993, Cancer research.

[183]  E. Offord,et al.  A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter , 1990, Journal of virology.

[184]  M. Botchan,et al.  Transformation mediated by the SV40 T antigens: Separation of the overlapping SV40 early genes with a retroviral vector , 1984, Cell.

[185]  David R. Scott,et al.  Determinants of Genital Human Papillomavirus Infection in Low‐Risk Women in Portland, Oregon , 1993, Sexually transmitted diseases.

[186]  A. Reingold,et al.  Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.

[187]  N. Letvin,et al.  Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.

[188]  S. Grossman,et al.  Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DMA-binding domain bound to its DNA target , 1992, Nature.

[189]  R. Schlegel,et al.  HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. , 1992, Virology.

[190]  N. Kiviat,et al.  The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations , 1993, Journal of virology.

[191]  J. Laurence,et al.  Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. , 1990, Blood.

[192]  W. A. Yeudall,et al.  Identification of human papillomavirus types in oral verruca vulgaris. , 1986, Journal of oral pathology.

[193]  M. Schiffman,et al.  Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. , 1992, Journal of the National Cancer Institute.

[194]  H. Mcdevitt,et al.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. , 1988, Nature.

[195]  H. Pfister,et al.  Duplication of enhancer sequences in human papillomavirus 6 from condylomas of the mamilla. , 1989, Virology.

[196]  R. Minnaar,et al.  Regulation of human papillomavirus type 16 (HPV-16) transcription by loci on the short arm of chromosome 11 is mediated by the TATAAAA motif of the HPV-16 promoter. , 1993, The Journal of general virology.

[197]  J. Hackett.  Salmonella-based vaccines. , 1990, Vaccine.

[198]  M. Feltkamp,et al.  Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells , 1993, European journal of immunology.

[199]  L. Koss.  Cytologic and histologic manifestations of human papillomavirus infection of the female genital tract and their clinical significance , 1987, Cancer.

[200]  N. Fusenig,et al.  Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. , 1987, Oncogene.

[201]  G. Demers,et al.  The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells , 1991, Journal of virology.

[202]  H. Yoshikawa,et al.  Detection of Human Antibody against the Human Papillomavirus Type 16 E7 Protein , 1991, Japanese journal of cancer research : Gann.

[203]  H. Hausen,et al.  Human papillomaviruses in Buschke-Löwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype , 1986, Journal of virology.

[204]  N. Christensen,et al.  The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. , 1991, Virology.

[205]  P. Mounts,et al.  Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells , 1990, Journal of virology.

[206]  H. Hausen,et al.  Rearranged HPV 16 molecules in an anal and in a laryngeal carcinoma , 1986, International journal of cancer.

[207]  B. Steinberg,et al.  Laryngeal papillomavirus infection during clinical remission. , 1983, The New England journal of medicine.

[208]  H. Wesch,et al.  HUMAN PAPILLOMAVIRUS INFECTIONS IN WOMEN WITH AND WITHOUT ABNORMAL CERVICAL CYTOLOGY , 1987, The Lancet.

[209]  J. DiPaolo,et al.  Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. , 1988, Carcinogenesis.

[210]  H. Hausen,et al.  Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung , 1985, Cancer.

[211]  D. Patel,et al.  An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16 , 1990, Journal of virology.

[212]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[213]  R. Weinberg,et al.  The retinoblastoma protein and the regulation of cell cycling. , 1992, Trends in biochemical sciences.

[214]  D. Danielpour,et al.  Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[215]  H. zur Hausen.  Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991, Virology.

[216]  P. Gruppuso,et al.  Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1. , 1990, Cancer research.

[217]  J. Dillner,et al.  Mapping of linear epitopes of human papillomavirus type 16: The L1 and L2 open reading frames , 1990, International journal of cancer.

[218]  E. de Villiers.  Heterogeneity of the human papillomavirus group , 1989, Journal of virology.

[219]  F. Wettstein,et al.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[220]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[221]  S. Yasumoto,et al.  Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene , 1991 .

[222]  T. Luger,et al.  Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha. , 1992, Journal of immunology.

[223]  H. Hausen.  Oncogenic Herpes viruses. , 1975, Biochimica et biophysica acta.

[224]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .

[225]  V. Defendi,et al.  Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[226]  P. Beard,et al.  Identification and characterization of novel promoters in the genome of human papillomavirus type 18 , 1993, Journal of virology.

[227]  K. Vousden,et al.  A point mutational analysis of human papillomavirus type 16 E7 protein , 1989, Journal of virology.

[228]  C. Wheeler,et al.  Determinants of Genital Human Papillomavirus Infection Among Cytologically Normal Women Attending the University of New Mexico Student Health Center , 1993, Sexually transmitted diseases.

[229]  Susan R. Johnson,et al.  Perinatal Vertical Transmission of Human Papillomavirus and Subsequent Development of Respiratory Tract Papillomatosis , 1991, The Annals of otology, rhinology, and laryngology.

[230]  R. Ren,et al.  Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice , 1992, Journal of virology.

[231]  G. S. Whitt,et al.  Evidence from 18S ribosomal RNA sequences that lampreys and hagfishes form a natural group. , 1992, Science.

[232]  N A Mitchison,et al.  Immune suppression genes. , 1989, Clinical and experimental immunology.

[233]  L. Brinton,et al.  Epidemiology of cervical cancer--overview. , 1992, IARC scientific publications.

[234]  W. Quint,et al.  Prevalence of human papillomavirus infections among heterosexual men and women with multiple sexual partners , 1992, Journal of medical virology.

[235]  K. Choo,et al.  Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. , 1987, Virology.

[236]  R. Steinman,et al.  Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275] , 1990, The Journal of experimental medicine.

[237]  E. Fuchs,et al.  Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation , 1988, The Journal of cell biology.

[238]  M. Loeken,et al.  Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen , 1988, Cell.

[239]  H. Pfister,et al.  Prevalence of antibodies to human papillomavirus type 8 in human sera , 1990, Journal of virology.

[240]  M. Yaniv,et al.  Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18 , 1988, Journal of virology.

[241]  F. Pass,et al.  Primary tissue culture of human wart-derived epidermal cells (keratinocytes). , 1975, Journal of the National Cancer Institute.

[242]  J. Nevins.  Transcriptional regulation. A closer look at E2F. , 1992, Nature.

[243]  J. Tam,et al.  Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. , 1992, Journal of immunology.

[244]  E. Fuchs,et al.  Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization , 1987, The Journal of cell biology.

[245]  U. Pettersson,et al.  Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. , 1990, The New biologist.

[246]  Y. Chardonnet,et al.  Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas , 1990, Journal of medical virology.

[247]  K. Vousden,et al.  Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages. , 1991, Journal of immunology.

[248]  J. Willey,et al.  Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. , 1991, Cancer research.

[249]  M. Middleton,et al.  Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes. , 1990, The Journal of investigative dermatology.

[250]  T. Nakajima,et al.  Detection of human papillomavirus dna in laryngeal squamous cell carcinomas by polymerase chain reaction , 1990, The Laryngoscope.

[251]  M. Mumby,et al.  Control of protein phosphatase 2A by simian virus 40 small-t antigen , 1991, Molecular and cellular biology.

[252]  Y. Chardonnet,et al.  Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. , 1990, Immunobiology.

[253]  C. Croce,et al.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[254]  M. Stanley,et al.  Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues. , 1991, American journal of obstetrics and gynecology.

[255]  J. McDougall,et al.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[256]  R. Zinkernagel,et al.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen , 1992, The Journal of experimental medicine.

[257]  D. Brachman,et al.  Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. , 1992, Cancer research.

[258]  G. Orth,et al.  Comparative studies on cell-mediated immunity in patients with different warts. , 1980, Dermatologica.

[259]  S. Syrjänen,et al.  Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. , 1983, International journal of oral surgery.

[260]  W. A. Jensen,et al.  Inhibition of protein kinase C results in decreased expression of bovine leukemia virus , 1992, Journal of virology.

[261]  B. Rouse,et al.  Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro , 1992, The Journal of experimental medicine.

[262]  K. Holmes,et al.  Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. , 1993, AIDS.

[263]  T. Golub,et al.  In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. , 1990, Oncogene.

[264]  K. Vousden.  Human papillomaviruses and cervical carcinoma. , 1989, Cancer cells.

[265]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[266]  C. Woodworth,et al.  Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. , 1993, The American journal of pathology.

[267]  P. Stern,et al.  Loss of MHC class‐I expression in cervical carcinomas , 1990, International journal of cancer.

[268]  L. Rudnicka,et al.  TGFβ-1 and TNFα expression in the epidermis of patients with epidermodysplasia verruciformis , 1991 .

[269]  W. Blattner,et al.  The epidemiology of the human T‐cell lymphotrophic virus type I and type II: etiologic role in human disease , 1991, Transfusion.

[270]  Myles A Brown,et al.  SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen , 1987, Cell.

[271]  S. Grossman,et al.  Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector , 1989, Journal of virology.

[272]  K. Münger,et al.  Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. , 1992, Cancer surveys.

[273]  J. Hofsteenge,et al.  Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. , 1991, Biochemistry.

[274]  J. Schneider,et al.  Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. , 1987, The EMBO journal.

[275]  J. Kaldor,et al.  The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain , 1992, International journal of cancer.

[276]  W. Pennie,et al.  Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro. , 1992, Virology.

[277]  M. Stoler,et al.  Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11 , 1987, International journal of cancer.

[278]  G. Orth,et al.  Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. , 1991, Virology.

[279]  S. Pyrhönen,et al.  Wart-virus antibodies and the prognosis of wart disease. , 1972, Lancet.

[280]  M. Prunieras,et al.  Natural substrates for the reconstruction of skin in vitro , 1984, The British journal of dermatology.

[281]  Wen-Hsiung Li,et al.  Fundamentals of molecular evolution , 1990 .

[282]  M. Yaniv,et al.  Structural and mutational analysis of E2 trans‐activating proteins of papillomaviruses reveals three distinct functional domains. , 1988, The EMBO journal.

[283]  J. McDougall,et al.  Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. , 1993, Carcinogenesis.

[284]  P. Lambert.  Papillomavirus DNA replication , 1991, Journal of virology.

[285]  R. Burk,et al.  Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. , 1992, Human pathology.

[286]  P. Gariglio,et al.  High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. , 1987, Cancer research.

[287]  I. Frazer,et al.  Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. , 1991, Virology.

[288]  E. de Villiers,et al.  Laboratory techniques in the investigation of human papillomavirus infection. , 1992, Genitourinary medicine.

[289]  W. Phelps,et al.  Cellular transformation by human papillomavirus DNA in vitro. , 1984, Science.

[290]  H. zur Hausen,et al.  Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. , 1992, Virology.

[291]  D. Galloway,et al.  Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18 , 1991, Journal of virology.

[292]  H. Hausen,et al.  Workshop on Papillomaviruses and Cancer , 1979 .

[293]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[294]  P. Holt.  Immune and inflammatory function in cigarette smokers. , 1987, Thorax.

[295]  C. Meijer,et al.  Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. , 1993, British Journal of Cancer.

[296]  A. Haase,et al.  In Situ Hybridization , 1989, Current Topics in Microbiology and Immunology.

[297]  R Reid,et al.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.

[298]  P. Rous,et al.  THE EFFECT OF CHEMICAL CARCINOGENS ON VIRUS-INDUCED RABBIT PAPILLOMAS , 1944, The Journal of experimental medicine.

[299]  S. Lippman,et al.  13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. , 1992, Journal of the National Cancer Institute.

[300]  B. Steinberg,et al.  Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx. , 1986, Cancer research.

[301]  I. Andó,et al.  EB virus induction is associated with B-cell maturation. , 1986, Immunology.

[302]  R. Schlegel,et al.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.

[303]  T. Sasazuki,et al.  HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans , 1987, Nature.

[304]  T. Crook,et al.  Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression , 1991, Journal of virology.

[305]  S. Beaudenon,et al.  Rearrangements of the upstream regulatory region of human papillomavirus type 6 can be found in both Buschke-Löwenstein tumours and in condylomata acuminata. , 1992, The Journal of general virology.

[306]  D. Lowy,et al.  Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA , 1987, Nature.

[307]  T. Crook,et al.  Continued expression of HPV‐16 E7 protein is required for maintenance of the transformed phenotype of cells co‐transformed by HPV‐16 plus EJ‐ras. , 1989, The EMBO journal.

[308]  S. Jabłońska,et al.  Role of Cell‐Mediated Immunity in Spontaneous Regression of Plane Warts , 1988, International journal of dermatology.

[309]  H. Mcdevitt,et al.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[310]  B. Müller-Hill,et al.  Easy identification of cDNA clones. , 1983, The EMBO journal.

[311]  J. Schiller,et al.  Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes , 1992, Journal of virology.

[312]  J. McDougall,et al.  Immortalization of primary human smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[313]  S. Syrjänen,et al.  HUMAN PAPILLOMAVIRUS DNA IN BRONCHIAL SQUAMOUS CELL CARCINOMAS , 1987, The Lancet.

[314]  C. Scott,et al.  Circulating B and T lymphocyte subpopulations in patients with genital warts , 1987, The British journal of clinical practice.

[315]  D. Lowy,et al.  Antigen presentation and T-cell activation in epidermodysplasia verruciformis. , 1990, The Journal of investigative dermatology.

[316]  J. Kreider,et al.  Experimental infection with human papillomavirus type 1 of human hand and foot skin. , 1990, Virology.

[317]  J. Cuzick,et al.  PROGRESSIVE POTENTIAL OF MILD CERVICAL ATYPIA: PROSPECTIVE CYTOLOGICAL, COLPOSCOPIC, AND VIROLOGICAL STUDY , 1986, The Lancet.

[318]  D. McCance,et al.  Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18 , 1990, Journal of virology.

[319]  J. Felsenstein.  CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP , 1985, Evolution; international journal of organic evolution.

[320]  T. Kirchhoff,et al.  Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears , 1992, Obstetrics and gynecology.

[321]  V. Band,et al.  Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells , 1991, Journal of virology.

[322]  M. Yaniv,et al.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes , 1989, Journal of virology.

[323]  D. McCance,et al.  Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type‐16 (HPV‐16) in sera from patients with cervical intraepithelial neoplasia and children , 1992, International journal of cancer.

[324]  S. Syrjänen,et al.  Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. , 1989, Acta oto-laryngologica.

[325]  B. Bernard,et al.  Human epidermis reconstructed by culture: is it "normal"? , 1986, The Journal of investigative dermatology.

[326]  L. Gissmann,et al.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[327]  J. Bourhis,et al.  Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA , 1990, The Lancet.

[328]  J. Kreider,et al.  The Shope papilloma-carcinoma complex of rabbits: a model system of neoplastic progression and spontaneous regression. , 1981, Advances in cancer research.

[329]  M. Yutsudo,et al.  Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice , 1991, Journal of virology.

[330]  G. Schoolnik,et al.  Human Papillomavirus Infection Sexually Active Adolescent Females: Prevalence and Risk Factors , 1990, Pediatric Research.

[331]  F. Noonan,et al.  Cis-urocanic acid, a product formed by ultraviolet B irradiation of the skin, initiates an antigen presentation defect in splenic dendritic cells in vivo. , 1988, The Journal of investigative dermatology.

[332]  J. Dillner,et al.  A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[333]  J. McDougall,et al.  Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. , 1989, The Journal of general virology.

[334]  S. Garland,et al.  The Absence of Genital Human Papillomavirus DNA in Virginal Women , 1992, International journal of STD & AIDS.

[335]  N. Auersperg,et al.  Karyotypic analysis of two related cervical carcinoma cell lines that contain human papillomavirus type 18 DNA and express divergent differentiation. , 1989, Cancer genetics and cytogenetics.

[336]  W. Rawls,et al.  Antibodies to human papillomavirus type 16 in patients with cervical neoplasia , 1990, The Lancet.

[337]  A. Taniguchi,et al.  Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region , 1991, Journal of virology.

[338]  S. Majewski.  Epidermodysplasia Verruciform is: Immunological and Clinical Aspects , 1994 .

[339]  J. Stéphenne.  Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. , 1988, Vaccine.

[340]  D. Miller,et al.  Chromosome analysis and alkaline phosphatase of C41, a cell line of human cervical origin distinct from HeLa. , 1977, Cancer research.

[341]  L. Brinton,et al.  Determinants of Genital Human Papillomavirus Infection in Low‐Income Women in Washington, D.C , 1993, Sexually transmitted diseases.

[342]  J. DiPaolo,et al.  Preferential sites for viral integration on mammalian genome. , 1989, Cancer genetics and cytogenetics.

[343]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.

[344]  R. Barrasso.  HPV-related genital lesions in men. , 1992, IARC scientific publications.

[345]  J. Ludes-Meyers,et al.  A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA , 1991, Journal of virology.

[346]  A. Batova,et al.  Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. , 1992, Cancer research.

[347]  B. Spiegelhalder,et al.  Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. , 1990, Carcinogenesis.

[348]  I. Mackay,et al.  ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MEN , 1986, The Lancet.

[349]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[350]  M. Yaniv,et al.  The BPV1‐E2 trans‐acting protein can be either an activator or a repressor of the HPV18 regulatory region. , 1987, The EMBO journal.

[351]  W. J. Halliday,et al.  Suppression of contact hypersensitivity by short-term ultraviolet irradiation: II. The role of urocanic acid. , 1988, Clinical and experimental immunology.

[352]  J. McDougall,et al.  HPV-18 immortalization of human keratinocytes. , 1989, Virology.

[353]  J. Whitton,et al.  A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[354]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[355]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[356]  P. Howley,et al.  Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation , 1988, Journal of virology.

[357]  J. Monaco,et al.  Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes , 1991, Nature.

[358]  T. Elliott,et al.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex , 1992, Nature.

[359]  A. Kligman,et al.  Isolation of wart virus in tissue culture. Successful reinoculation into humans. , 1961, Archives of dermatology.

[360]  F. X. Bosch,et al.  Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer , 1992, Journal of clinical microbiology.

[361]  S. Schneider-Maunoury,et al.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression , 1991, Journal of virology.

[362]  M. Lehtinen,et al.  Pre‐ and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma , 1992, Journal of medical virology.

[363]  A. Husband.  Novel vaccination strategies for the control of mucosal infection. , 1993, Vaccine.

[364]  D. Pim,et al.  Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. , 1992, Oncogene.

[365]  W. A. Yeudall,et al.  Human papillomavirus type 2 DNA in oral verrucous carcinoma. , 1986, Journal of oral pathology.

[366]  L. Young,et al.  Epstein–Barr virus infection and replication in a human epithelial cell system , 1992, Nature.

[367]  P. Howley,et al.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters , 1990, Journal of virology.

[368]  J. Kreider,et al.  Papillomas and carcinomas in transgenic rabbits carrying EJ-ras DNA and cottontail rabbit papillomavirus DNA , 1993, Journal of virology.

[369]  G. Orth,et al.  A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. , 1980, The Journal of investigative dermatology.

[370]  J. Drijfhout,et al.  Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[371]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[372]  F. Graham,et al.  Use of human adenovirus-based vectors for antigen expression in animals. , 1989, The Journal of general virology.

[373]  C. Woodworth,et al.  Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma , 1989, Journal of virology.

[374]  J. Oriel.  Natural history of genital warts. , 1971, The British journal of venereal diseases.

[375]  P. Fuchs,et al.  Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri , 1988, International journal of cancer.

[376]  L. Brinton,et al.  Human Papillomaviruses and Other Influences on Survival From Cervical Cancer in Panama , 1993, Obstetrics and gynecology.

[377]  G. Snow,et al.  Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. , 1992, The Journal of general virology.

[378]  F. Wettstein.  Papillomaviruses and Carcinogenic Progression I , 1987 .

[379]  G. Snow,et al.  The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. , 1990, The Journal of general virology.

[380]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[381]  F. Brodsky,et al.  The cell biology of antigen processing and presentation. , 1991, Annual review of immunology.

[382]  D. Lowy,et al.  The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. , 1990, The EMBO journal.

[383]  I. Puisieux,et al.  Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. , 1993, Science.

[384]  E. Stanbridge,et al.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. , 1986, The EMBO journal.

[385]  L. Villa,et al.  Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. , 1988, The Journal of general virology.

[386]  M. Botchan,et al.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. , 1990, Science.

[387]  J. Dillner,et al.  Antibodies against papillomavirus antigens in cervical secretions from condyloma patients , 1993, Journal of clinical microbiology.

[388]  K. Holmes,et al.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection , 1992, The New England journal of medicine.

[389]  J. Felsenstein.  Numerical Methods for Inferring Evolutionary Trees , 1982, The Quarterly Review of Biology.

[390]  F. X. Bosch,et al.  HPV and cervical neoplasia: review of case-control and cohort studies. , 1992, IARC scientific publications.

[391]  C. Woodworth,et al.  Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. , 1992, Cancer research.

[392]  L. Rudnicka,et al.  Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. , 1990, Journal of the American Academy of Dermatology.

[393]  P. Jahrling,et al.  Replication of hemorrhagic fever viruses in monocytic cells. , 1989, Reviews of infectious diseases.

[394]  S. Comerford,et al.  T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes. , 1992, The Journal of general virology.

[395]  B. Chain,et al.  Cancer of the cervix: prospects for immunological control. , 1991, International journal of experimental pathology.

[396]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[397]  M. Campo,et al.  Papillomavirus infection in cattle: viral and chemical cofactors in naturally occurring and experimentally induced tumours. , 1986, Ciba Foundation symposium.

[398]  D. Galloway,et al.  Evidence of prevalent genital-type human papillomavirus infections in adults and children. , 1990, The Journal of infectious diseases.

[399]  J. Rhim,et al.  Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. , 1989, Virology.

[400]  P. Howley,et al.  Functional analysis of E2-mediated repression of the HPV18 P105 promoter. , 1991, The New biologist.

[401]  P. Rous,et al.  THE PROGRESSION TO CARCINOMA OF VIRUS-INDUCED RABBIT PAPILLOMAS (SHOPE) , 1935, The Journal of experimental medicine.

[402]  M. Bender.  Concepts of wart regression. , 1986, Archives of dermatology.

[403]  H. Pfister.  Relationship of papillomaviruses to anogenital cancer. , 1987, Obstetrics and gynecology clinics of North America.

[404]  L. Chen,et al.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[405]  F. Graham,et al.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides , 1991, Journal of virology.

[406]  H. Hausen.  Genital papillomavirus infections. , 1985 .

[407]  T. Crook,et al.  Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53‐mediated repression of transcription. , 1992, The EMBO journal.

[408]  D. Mason,et al.  Langerhans’cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia , 1983, British journal of obstetrics and gynaecology.

[409]  K. Münger,et al.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[410]  I. Frazer,et al.  A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[411]  G. Orth,et al.  Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes , 1992, Nature.

[412]  M. Chin,et al.  Identification of human papillomavirus type 11 E4 gene products in human tissue implants from athymic mice. , 1988, Virology.

[413]  P. Spradbrow.  Immune Response to Papillomavirus Infection , 1987 .

[414]  Galloway Da.  Serological assays for the detection of HPV antibodies. , 1992 .

[415]  W. Lancaster,et al.  Amplification of human papillomavirus DNA sequences by using conserved primers , 1989, Journal of clinical microbiology.

[416]  S. Akira,et al.  NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region , 1993, Journal of virology.

[417]  P. Fuchs,et al.  Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. , 1988, The Journal of investigative dermatology.

[418]  J. Streilein.  Sunlight and skin-associated lymphoid tissues (SALT): if UVB is the trigger and TNF alpha is its mediator, what is the message? , 1993, The Journal of investigative dermatology.

[419]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[420]  B. Vogelstein,et al.  Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. , 1992, Oncogene.

[421]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[422]  H. Bernard,et al.  Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. , 1990, Nucleic acids research.

[423]  J. DiPaolo,et al.  Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. , 1987, Cytogenetics and cell genetics.

[424]  J. Teyssier.  The chromosomal analysis of human solid tumors. A triple challenge. , 1989, Cancer genetics and cytogenetics.

[425]  I. Kato,et al.  Human papillomavirus type 16 E7 gene sequence in human cervical carcinoma analysed by polymerase chain reaction and direct sequencing , 1990 .

[426]  S. Stacey,et al.  Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera. , 1992, The Journal of general virology.

[427]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[428]  G. Temple,et al.  Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. , 1990, American journal of obstetrics and gynecology.

[429]  H. zur Hausen,et al.  Condylomata acuminata and human genital cancer. , 1976, Cancer research.

[430]  N. Kiviat,et al.  Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carcinoma? , 1992, IARC scientific publications.

[431]  B. Chain,et al.  Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[432]  T. Crook,et al.  p53 point mutation in HPV negative human cervical carcinoma cell lines. , 1991, Oncogene.

[433]  G. Orth,et al.  DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 5 DNA IN SKIN CANCERS OF AN IMMUNOSUPPRESSED RENAL ALLOGRAFT RECIPIENT , 1983, The Lancet.

[434]  Y. Chardonnet,et al.  Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV). , 1977, Clinical and experimental immunology.

[435]  C. Thomssen,et al.  Occurrence of antibodies TO L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls , 1991, International journal of cancer.

[436]  J. Wilson,et al.  Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[437]  J. Walboomers,et al.  General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions , 1992, Journal of clinical microbiology.

[438]  N. Kiviat,et al.  Tolerance and efficacy of recombinant human interferon gamma in the treatment of refractory genital warts. , 1988, American Journal of Medicine.

[439]  S. Oroszlan,et al.  Human Wart Virus: In vitro Cultivation , 1964, Science.

[440]  M. Van Ranst,et al.  Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. , 1992, The Journal of general virology.

[441]  G. Orth,et al.  Immunological studies in epidermodysplasia verruciformis. , 1978, Bulletin du cancer.

[442]  E. de Villiers,et al.  Multiple infections in cases of cervical cancer from a high‐incidence area in tropical Africa , 1989, International journal of cancer.

[443]  M. Campo,et al.  Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types , 1990, Veterinary Record.

[444]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[445]  J. F. Young,et al.  Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. , 1992, Vaccine.

[446]  M. Pagano,et al.  Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. , 1992, Oncogene.

[447]  E. Stanbridge.  Human tumor suppressor genes. , 1990, Annual review of genetics.

[448]  Armin Ensser,et al.  Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region , 1990, Nucleic Acids Res..

[449]  N. Prose,et al.  Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection. , 1990, Journal of the American Academy of Dermatology.

[450]  T. Hunt,et al.  HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. , 1993, Oncogene.

[451]  B. Gloss,et al.  Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer , 1989, Journal of virology.

[452]  T. Braciale,et al.  Antigen presentation: structural themes and functional variations. , 1991, Immunology today.

[453]  M. Campo,et al.  Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. , 1992, Cancer research.

[454]  G. Snow,et al.  Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology , 1992, International journal of cancer.

[455]  A. Levine,et al.  Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.

[456]  D. Vlček,et al.  Presence and type specificity of papillomavirus antibodies demonstrable by immunoelectron microscopy tests in samples from patients with warts. , 1990, The Journal of general virology.

[457]  D. Phillips,et al.  Smoking-related DNA adducts in human cervical biopsies. , 1993, IARC scientific publications.

[458]  L. Brinton,et al.  Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. , 1990, Cancer research.

[459]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[460]  M. Stanley,et al.  Properties of a non‐tumorigenic human cervical keratinocyte cell line , 1989, International journal of cancer.

[461]  P. Chambon,et al.  Transcriptional enhancer factor (TEF)‐1 and its cell‐specific co‐activator activate human papillomavirus‐16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. , 1992, The EMBO journal.

[462]  L. Turek,et al.  Transcriptional regulation of the human papillomavirus‐16 E6‐E7 promoter by a keratinocyte‐dependent enhancer, and by viral E2 trans‐activator and repressor gene products: implications for cervical carcinogenesis. , 1987, The EMBO journal.

[463]  H. Abcarian,et al.  The effectiveness of immunotherapy in the treatment of anal condyloma acuminatum. , 1977, The Journal of surgical research.

[464]  R. F. Marshall,et al.  Immunization against bovine papillomavirus infection. , 1986, Ciba Foundation symposium.

[465]  K. Syrjänen,et al.  Histological evidence for the presence of condylomatous epithelial lesions in association with laryngeal squamous cell carcinoma. , 1981, ORL; journal for oto-rhino-laryngology and its related specialties.

[466]  Stephen H. Friend,et al.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.

[467]  T. Crook,et al.  Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell lines , 1991, Molecular carcinogenesis.

[468]  M. von Knebel Doeberitz,et al.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. , 1988, Cancer research.

[469]  K. Münger,et al.  The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein , 1993, Journal of virology.

[470]  J. Almeida,et al.  Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. , 1965, Lancet.

[471]  Immunobiology of papillomavirus. Prospects for vaccination , 1992 .

[472]  J. Hurwitz,et al.  Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[473]  K. Shah,et al.  Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[474]  M. Hagensee,et al.  Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins , 1993, Journal of virology.

[475]  I. Smith,et al.  Human papillomavirus infections in a group of renal transplant recipients , 1986, The British journal of dermatology.

[476]  E Bell,et al.  The reconstitution of living skin. , 1983, The Journal of investigative dermatology.

[477]  M. Schiffman,et al.  Determinants of genital human papillomavirus infection in young women. , 1991, Journal of the National Cancer Institute.

[478]  J. Best,et al.  Towards vaccines against human papillomavirus type-16 genital infections. , 1993, Vaccine.

[479]  S. Baylin,et al.  The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[480]  M. Ustav,et al.  Transient replication of BPV‐1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. , 1991, The EMBO journal.

[481]  H. Stein,et al.  Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. , 1990, Journal of clinical pathology.

[482]  H. Bernard,et al.  Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree , 1991, Journal of clinical microbiology.

[483]  M. Jenkins,et al.  Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. , 1988, Journal of immunology.

[484]  J. Kreider,et al.  Shope rabbit papilloma--carcinoma complex. A model system of HPV infections. , 1985, Clinics in dermatology.

[485]  Y. L. Lin,et al.  Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins , 1993, Journal of virology.

[486]  D. Sugarbaker,et al.  High frequency of retinoic acid receptor beta abnormalities in human lung cancer. , 1991, Oncogene.

[487]  H. zur Hausen.  Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. , 1986, Lancet.

[488]  K. Shah,et al.  Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas , 1983, Cancer.

[489]  M. Rosen,et al.  Duplication of the upstream regulatory sequences increases the transformation potential of human papillomavirus type 11. , 1991, Virology.

[490]  M. Pawlita,et al.  Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. , 1992, The Journal of general virology.

[491]  H. Sato,et al.  Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells. , 1989, Virology.

[492]  W. Quint,et al.  Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and southern‐blot analysi , 1989, Journal of medical virology.

[493]  K. Münger,et al.  Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[494]  S. Yousem,et al.  Occurrence of Human Papillomavirus DNA in Primary Lung Neoplasms , 1992, Cancer.

[495]  R. Garcea,et al.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles , 1993, Journal of virology.

[496]  J. Sundberg,et al.  Neoplasms of Equidae. , 1977, Journal of the American Veterinary Medical Association.

[497]  E. Fuchs,et al.  Regulation of terminal differentiation of cultured human keratinocytes by vitamin A , 1981, Cell.

[498]  T. Iftner,et al.  Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium , 1992, Journal of virology.

[499]  N. Park,et al.  Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. , 1991, Carcinogenesis.

[500]  V. Defendi,et al.  Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. , 1991, The American journal of pathology.

[501]  J. McDougall,et al.  Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. , 1991, The American journal of pathology.

[502]  H. Hausen,et al.  Molecular cloning and characterization of the dna of a new human papillomavirus (hpv 30) from a laryngeal carcinoma , 1986, International journal of cancer.

[503]  R. Lechler,et al.  Antigen presentation by keratinocytes induces tolerance in human T cells , 1990, European journal of immunology.

[504]  F. X. Bosch,et al.  Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines , 1991, Journal of virology.

[505]  R. Karr,et al.  The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells , 1990, The Journal of experimental medicine.

[506]  M. Krcmar,et al.  Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination. , 1991, The Journal of general virology.

[507]  W. Pennie,et al.  Analysis of the transforming functions of bovine papillomavirus type 4. , 1993, Virology.

[508]  S Wacholder,et al.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. , 1993, Journal of the National Cancer Institute.

[509]  R. Shope.  IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSIS , 1937, The Journal of experimental medicine.

[510]  H. Hausen,et al.  Selective suppression of human papillomavirus transcription in non‐tumorigenic cells by 5‐azacytidine. , 1988, The EMBO journal.

[511]  M. Stanley,et al.  Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease , 1991, The Journal of pathology.

[512]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[513]  J. Saurat,et al.  Pemphigoid, pemphigus and Pr antigens in adult human keratinocytes grown on nonviable substrates. , 1982, The Journal of investigative dermatology.

[514]  L. Vigilant.  Evolution of human mitochondrial DNA , 1996 .

[515]  J. Kaldor,et al.  Risk factors for cervical cancer in Colombia and Spain , 1992, International journal of cancer.

[516]  O. Haas,et al.  Cytogenetic findings in cervical carcinoma. A statistical approach. , 1991, Cancer genetics and cytogenetics.

[517]  R. Weber,et al.  Prevalence of human papillomavirus in inverted nasal papillomas. , 1988, Archives of otolaryngology--head & neck surgery.

[518]  H. Hausen,et al.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers , 1989 .

[519]  R. Lathe,et al.  Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. , 1991, Virology.

[520]  G. Freeman,et al.  Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression , 1992, Nature.

[521]  I. Frazer,et al.  Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. , 1992, Virology.

[522]  M. Botchan,et al.  Activation of BPV-1 replication in vitro by the transcription factor E2 , 1991, Nature.

[523]  A. Ferenczy,et al.  Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections , 1989, Obstetrics and gynecology.

[524]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[525]  F. Hoppe-Seyler,et al.  Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1 , 1991, Journal of virology.

[526]  D. Maccallum,et al.  Fine structure of subcultivated stratified squamous epithelium grown on collagen rafts. , 1980, Experimental cell research.

[527]  M. Scheffner,et al.  Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 , 1993, Molecular and cellular biology.

[528]  O. Baadsgaard,et al.  The Cellular Immune Response to Human Papillomavirus Infection , 1990, International journal of dermatology.

[529]  B. Rollins,et al.  Suppression of tumor formation in vivo by expression of the JE gene in malignant cells , 1991, Molecular and cellular biology.

[530]  M. Campo,et al.  Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination , 1990, Veterinary Record.

[531]  J. Walboomers,et al.  General primer‐mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas , 1990, International journal of cancer.

[532]  F. Rösl,et al.  The effect of DNA methylation on gene regulation of human papillomaviruses. , 1993, The Journal of general virology.

[533]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[534]  C. Woodworth,et al.  Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. , 1990, Cancer research.

[535]  H. Hamada,et al.  Characterization of a cell type‐specific enhancer found in the human papilloma virus type 18 genome. , 1987, The EMBO journal.

[536]  L. Schnipper,et al.  Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo) , 1992, Molecular and cellular biology.

[537]  M. Campo.  Vaccination against papillomavirus. , 1991, Cancer cells.

[538]  G. Orth,et al.  Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. , 1986, Journal of the American Academy of Dermatology.

[539]  J. McDougall,et al.  Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human keratinocytes transformed by nitrosomethylurea. , 1993, Oncogene.

[540]  Y. Collan,et al.  Human papillomavirus DNA in squamous cell carcinomas of the larynx demonstrated by in situ DNA hybridization. , 1987, ORL; journal for oto-rhino-laryngology and its related specialties.

[541]  S. Wacholder,et al.  The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. , 1992, Archives of pathology & laboratory medicine.

[542]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[543]  E. Schwarz.  Transcription of Papillomavirus Genomes , 1987 .

[544]  David E. Irwin,et al.  Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[545]  J. Shay,et al.  A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.

[546]  C. Mackay,et al.  Adhesion in Leukocyte Homing and Differentiation , 1993, Current Topics in Microbiology and Immunology.

[547]  J. Icenogle,et al.  Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. , 1991, Virology.

[548]  T. Luger,et al.  Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. , 1991, Cellular immunology.

[549]  J. Allison,et al.  Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. , 1993, Science.

[550]  M. Schiffman.  Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. , 1992, IARC scientific publications.

[551]  B. Gloss,et al.  The upstream regulatory region of the human papilloma virus‐16 contains an E2 protein‐independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. , 1987, The EMBO journal.

[552]  M. Schiffman,et al.  Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA , 1991, Journal of clinical microbiology.

[553]  J. G. Stevens,et al.  Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[554]  T. Crook,et al.  Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. , 1992, The EMBO journal.

[555]  H. Hausen,et al.  The Role of Papillomaviruses in Human Anogenital Cancer , 1987 .

[556]  M. Lutzner.  Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. , 1978, Bulletin du cancer.

[557]  H. Hausen,et al.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. , 1984, The EMBO journal.

[558]  C. Woodworth,et al.  Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells , 1990, Journal of virology.

[559]  G. Orth,et al.  Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. , 1992, The Journal of investigative dermatology.

[560]  M. Maiman,et al.  Colposcopic Evaluation of Human Immunodeficiency Virus-Seropositive Women , 1991, Obstetrics and gynecology.

[561]  E. Androphy.  Papillomaviruses and interferon. , 1986, Ciba Foundation symposium.

[562]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[563]  S. Jabłońska,et al.  Langerhans cells in epidermodysplasia verruciformis. , 1987, Dermatologica.

[564]  S. Vermund,et al.  Human papillomavirus infection and other risk factors for cervical neoplasia: A case‐control study , 1991, International journal of cancer.

[565]  R. Zaino,et al.  Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata , 1985, Nature.

[566]  F. Esteban,et al.  Presence of hpv 16 sequences in laryngeal carcinomas , 1990, International journal of cancer.

[567]  C. Meijer,et al.  Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites , 1992, Journal of virology.

[568]  M. Francis.  Synthetic peptides. , 1996, Methods in molecular medicine.

[569]  M. von Knebel Doeberitz,et al.  Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[570]  R. Schlegel,et al.  Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. , 1988, The EMBO journal.

[571]  R. Kimmig,et al.  Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. , 1989, Journal of the National Cancer Institute.

[572]  M. Stanley,et al.  Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. , 1993, The Journal of general virology.

[573]  M. Inoue,et al.  Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. , 1992, Cancer research.

[574]  Wen-Hsiung Li,et al.  Understanding the origins of AIDS viruses , 1988, Nature.

[575]  L. Banks,et al.  Baculovirus expression of the human papillomavirus type 16 capsid proteins: detection of L1-L2 protein complexes. , 1991, The Journal of general virology.

[576]  Shope,et al.  INFECTIOUS PAPILLOMATOSIS OF RABBITS , 1933, The Journal of experimental medicine.

[577]  M. Sporn,et al.  Transforming growth factors. , 1985, Cancer surveys.

[578]  B. Gloss,et al.  The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription , 1991, Journal of virology.

[579]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.